NEURONETICS
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment.
NEURONETICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2003-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.neurostar.com
Total Employee:
101+
Status:
Active
Contact:
877-600-7555
Email Addresses:
[email protected]
Total Funding:
313.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Photometics
Photometics develops infrared light-based therapy for skin cancer.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
J Carlo Cannell
J Carlo Cannell investment in Post-IPO Equity - Neuronetics
Solar capital
Solar capital investment in Post-IPO Debt - Neuronetics
Investor Growth Capital Limited
Investor Growth Capital Limited investment in Series G - Neuronetics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series G - Neuronetics
Accuitive Medical Ventures
Accuitive Medical Ventures investment in Series G - Neuronetics
Industry Ventures
Industry Ventures investment in Series G - Neuronetics
ONSET Ventures
ONSET Ventures investment in Series G - Neuronetics
GE Ventures
GE Ventures investment in Series G - Neuronetics
KBL Healthcare Ventures
KBL Healthcare Ventures investment in Series G - Neuronetics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series G - Neuronetics
Official Site Inspections
http://www.neurostar.com Semrush global rank: 686.07 K Semrush visits lastest month: 61.79 K
- Host name: 64.91.240.150
- IP address: 64.91.240.150
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Neuronetics"
Home Page - NeuroStar
NeuroStar is focused, local treatment at the source of your depression, without the side effects of medication. n addition to treating Major Depression (MDD), NeuroStar TMS is now FDA …See details»
TMS NeuroStar - Glaser & Randhawa
NeuroStar is now FDA-cleared as a first-line treatment for adolescents with depression, making it the FIRST and ONLY TMS therapy cleared as an adjunct (add-on) for patients ages 15 and older. Check out our video to learn more! …See details»
Neuronetics, Inc. | LinkedIn
Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder and other mental...See details»
Neuronetics - Wikipedia
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration (FDA) a…See details»
Healthcare Professional Resources - NeuroStar
NeuroStar is the market leader in TMS clinical practice, with over 1,100 practices offering NeuroStar, and more than 100 NeuroStar supporting team members. Studies show that with …See details»
Mission & Values - NeuroStar
NeuroStar is the leading TMS (transcranial magnetic stimulation) treatment for major depressive disorder. With over 6.9 million treatment sessions delivered, NeuroStar has transformed …See details»
Transcranial Magnetic Stimulation - Lindner Center of …
Transcranial Magnetic Stimulation (TMS) Therapy is an innovative non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms, restoring HOPE to those struggling to live their lives. What …See details»
Neuronetics - Crunchbase Company Profile & Funding
Neuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders. Neuronetics may be growing as evidenced by a reported 12% increase in revenue and the expansion of its …See details»
Neurostar - Crunchbase Company Profile & Funding
Neurostar develops and manufactures systems for Deep Brain Stimulation (DBS) surgeries and ultraprecise motorized stereotaxic. In their efforts to dynamically increase the company’s product range, they are stressing the importance of …See details»
Why Neurostar - NeuroStar
At NeuroStar ®, we care about the success of your practice, and we care about helping you improve patient outcomes. We are committed to improving quality of life for people suffering from depression. We help you succeed with the most …See details»
NeuroStar® Transcranial Magnetic Stimulation: Solutions for …
Aug 10, 2023 · NeuroStar is accompanied by technology and resources that support management and ease of use. The NeuroStar® Contact Sensing system ensures that the prescribed dose …See details»
Neuronetics Announces NeuroStar® Advanced Therapy for
Nov 14, 2022 · NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5 million treatments delivered. NeuroStar is …See details»
Neuronetics and Greenbrook TMS Announce Definitive …
Aug 12, 2024 · By creating a vertically-integrated organization capable of providing access to TMS therapy with significant scale, the acquisition offers multiple strategic benefits for …See details»
Advanced TMS Therapy - Remisson Is Very Possible at A New …
NeuroStar Advanced TMS Therapy is a safe, FDA-cleared therapy that helps people who struggle with depression. Call us today 303-798-2196See details»
Neuronetics Receives MDSAP Certification and CE Mark …
May 8, 2023 · The Company has received CE Mark Certification for NeuroStar Advanced Therapy under the new Medical Device Regulation (MDR) in the European Union (EU) and the Medical …See details»
myneurostar.com
The NeuroStar consultation guide provides information on how NeuroStar TMS therapy works and its benefits for treating depression, anxiety, and OCD.See details»
Diamond Lake Clinic - NeuroStar
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms …See details»
Neurostars
Course information and discussions organised by different Neuroscience community/organisations. This is the workspace for the INCF Google Summer of Code ( …See details»
TAP INTO A NEW POSSIBILITY - neurostar.com
NeuroStar TMS (Transcranial Magnetic Stimulation) goes right to the source of depression – your brain. It is a non-invasive, non-drug treatment that uses focused magnetic pulses to “wake up” …See details»
TrakStar®
About. Please give us a moment. TrakStar is loading your data...See details»